Skip to main content
. 2002 Jan;46(1):196–202. doi: 10.1128/AAC.46.1.196-202.2002

TABLE 5.

Susceptibilities to potentially active drugs of all isolates of ESBL-positive Enterobacteriaceaea

ESBL type No. of isolates % Susceptibility to drug
Imipenem Cefoxitin Amoxicillin plus clavulanate Piperacillin plus tazobactam Ampicillin plus sulbactam Gentamicin Amikacin Ciprofloxacin
TEM+ 234 99.6 79 82 95 69 45 68 32
SHV+ 173 100 79 88 88 59 66 86 85
TEM+ and SHV+ 55 100 75 78 84 47 71 69 76
Non-TEM/non-SHV 38 100 76 97 89 39 55 95 71
    Total 500 99.8 78 85 91 61 56 76 58
a

MICs have been interpreted according to current NCCLS criteria (23).